GH Q1 2026 Earnings EPS Beats Estimates Amidst Focus on Precision Oncology IIPR Q1 2026 Earnings EPS Misses Estimates as Cannabis Real Estate Yields Mixed Results CCID Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher PDS Biotechnology Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Up 345 CDZIP Q1 2026 Earnings NarrowerThanExpected Loss Reflects Cost Discipline Amid Water Resource Development KURA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Navigates Development